A Study Using Non-Invasive ECG Imaging Technology to Save Time During Surgery to Correct Irregular Heartbeat (Ventricular Arrhythmia Ablation)


About this study

The purpose of this study is to assess the time savings of VIVO device to guide ventricular ablation procedures compared to standard-of-care procedures utilizing electroanatomical mapping systems.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • At least 18 years of age.
  • Structurally normal heart.
  • Cardiac MRI/CT as part of standard of care.
  • Diagnosed with premature ventricular contractions or ventricular tachycardia and scheduled to undergo an ablation to treat these conditions.

Exclusion Criteria:

  • Less than 18 years of age.
  • Structurally abnormal heart.


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Fred Kusumoto, M.D.

Contact us for the latest status

Contact information:

Kamal Preet Cheema M.D.



More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available